What People Get Wrong About Sjögren’s
Read More
Novartis’ investigational therapy for Sjögren’s disease receives FDA Breakthrough Therapy designation
Read MoreStart 2026 Strong: Your Annual Sjögren’s Care Checklist
Read More
2025 in Review: A Defining Year for Sjögren’s
Read MoreFirst-Ever Peripheral Nervous System Clinical Practice Guideline for Sjögren’s Disease Accepted for Publication
Read MoreThe Future Is Here for Sjögren’s: A Recap of the ACR Convergence Conference in Chicago
Read MoreFNIH Biomarkers Consortium Targets Faster Diagnosis, Better Treatments for Sjögren’s Disease
Read MoreSjögren's Disease Update Requested in FY26 House Appropriations Committee Report
Read MoreSjögren’s Foundation Celebrates Release of First-Ever National Institutes of Health Strategic Plan for Autoimmune Disease Research
Read MoreFirst ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren’s disease.
Read More
The Living with Sjögren's Patient Survey is Now Open
Read MoreSjögren’s Foundation Joins Leading Autoimmune Organizations in Supporting the Launch of Vie Ventures
Read More